Standard Biotools (LAB) Other Operating Expenses (2010 - 2025)

Standard Biotools (LAB) has 16 years of Other Operating Expenses data on file, last reported at -$10.5 million in Q4 2025.

• On a quarterly basis, Other Operating Expenses rose 15.8% year-over-year to -$10.5 million in Q4 2025; TTM through Mar 2026 was -$8.8 million, a 1679.92% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 82.7% from the prior year.
• Other Operating Expenses for Q4 2025 stood at -$10.5 million, down from $43000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for LAB reached as high as $43.2 million in Q3 2021 and fell as low as -$12.5 million in Q4 2024.
• Historically, Other Operating Expenses has averaged $6.3 million across 5 years, with a median of $4.3 million in 2024.
• Across the five-year window, Other Operating Expenses jumped 18388.89% in 2023 and sank 331.5% in 2024, its largest moves.
• Year by year, Other Operating Expenses stood at $43.2 million in 2021, then tumbled by 86.4% to $5.9 million in 2022, then declined by 7.88% to $5.4 million in 2023, then plunged by 331.5% to -$12.5 million in 2024, then gained by 15.8% to -$10.5 million in 2025.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$10.5 million in Q4 2025, $43000.0 in Q3 2025, and $1.7 million in Q2 2025.